Data / Form D filings / Rhinal Therapeutics Inc.
Rhinal Therapeutics Inc.: Form D filing
Rhinal Therapeutics Inc., a biotechnology company in Las Vegas, NV, filed a Form D with the SEC in 2025. The latest, on August 7, 2025, reports $20,000 sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 732 S 6TH ST, 4248, Las Vegas, NV, 89101
- Phone
- (702) 981-6980
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2023
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2080382
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | New notice | $1,000,000 | $20,000 | $980,000 | 1 | Jul 28, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lawrence Fox | Executive Officer, Director | |
| Mike George | Director | |
| Austin Panhans | Executive Officer | |
| Frank Puglisi | Executive Officer, Director | |
| Robert Clayborough | Executive Officer, Director |
Other biotechnology companies in Nevada that filed recently
- Palimpsest Bio Corp. $172,000 · Oct 30, 2026
- Conexeu Sciences Inc. $1.5 million · Oct 21, 2026
Every Form D from the week of Aug 4, 2025 · All recent filings in Nevada · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Rhinal Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.